Tom Kerppola;The Regents of the University of Michigan;Millendo Therapeutics, Inc.
发明人:
Gary Hammer,Tom Kerppola,Raili Kerppola
申请号：
US15839647
公开号：
US20180256524A1
申请日:
2017.12.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
